G-protein-coupled receptor (GPCR) signaling is essential for the spatiotemporal control of leukocyte dynamics during immune responses. For efficient navigation through mammalian tissues, most leukocyte types express more than one GPCR on their surface and sense a wide range of chemokines and chemoattractants, leading to basic forms of leukocyte movement (chemokinesis, haptokinesis, chemotaxis, haptotaxis, and chemorepulsion). How leukocytes integrate multiple GPCR signals and make directional decisions in lymphoid and inflamed tissues is still subject of intense research. Many of our concepts on GPCR-controlled leukocyte navigation in the presence of multiple GPCR signals derive from in vitro chemotaxis studies and lower vertebrates. In this review, we refer to these concepts and critically contemplate their relevance for the directional movement of several leukocyte subsets (neutrophils, T cells, and dendritic cells) in the complexity of mouse tissues. We discuss how leukocyte navigation can be regulated at the level of only a single GPCR (surface expression, competitive antagonism, oligomerization, homologous desensitization, and receptor internalization) or multiple GPCRs (synergy, hierarchical and non-hierarchical competition, sequential signaling, heterologous desensitization, and agonist scavenging). In particular, we will highlight recent advances in understanding GPCR-controlled leukocyte navigation by intravital microscopy of immune cells in mice.
| INTRODUC TI ON
Innate and adaptive immune responses depend on the coordination and spatiotemporal control of leukocyte dynamics between and within lymphoid organs and peripheral tissues. A wide spectrum of chemically diverse molecules including small proteins, peptides, lipids, nucleotides, and extracellular matrix fragments can act as chemoattractants, regulating leukocyte motility, migration, chemotaxis, positioning, and cell-cell interaction. Leukocytes perceive these signals mainly through G-protein-coupled receptors (GPCRs) that, upon agonist binding, induce intracellular promigratory responses. 1, 2 Based on the cell type-specific expression of cell surface GPCR type combinations and intracellular GPCR-controlling protein networks, each leukocyte subset has evolved specific trafficking paths to fulfill their designated effector functions in the body. [3] [4] [5] Over the last decades, the analysis of GPCR-deficient mouse models has advanced our understanding of how specific GPCR signals determine immune cell positioning and compartmentalization in situ. Recent work now also started to shed light on the establishment of chemokine patterns and chemotactic fields that guide leukocytes in mammalian tissues. 6, 7 In particular, intravital imaging of control and GPCRdeficient leukocytes in tissues of live anesthetized mice has brought unprecedented insight into the dynamic migration patterns of immune cell subsets in situ. 8, 9 Despite these achievements, it is still largely unclear how leukocytes make directional decisions in lymphoid and inflamed organs where they constantly encounter GPCR signals emanating from multiple sources. The detailed mechanisms of how leukocytes sense, integrate, and prioritize between multiple chemotactic fields in situ and how this influences their physiological trafficking are still largely unknown. Dissecting these molecular events experimentally in mammalian tissues is very challenging and demanding. In particular, we are missing important pieces of information (eg, the exact distribution and concentrations of known chemottractant, GPCR dynamics in leukocytes) and cannot control for unknown chemotactic fields. Due to these current limitations many of the emerging concepts for leukocyte navigation in complex chemoattractant milieus come from studies in controlled in vitro systems 2 or lower model organisms. 10, 11 However, these concepts from reductionist models may not always be easily translatable to the complex situation in mammalian lymphoid organs and inflamed peripheral tissues. In recent years, several systematic studies in mice have started to disentangle how multiple GPCR signals shape leukocyte migration patterns in the complexity of mammalian tissues.
In this review, we will summarize common concepts and mechanisms of GPCR-controlled leukocyte navigation coming from studies with mouse and human leukocytes. We outline the protein networks that control GPCR signaling and GPCR activity and discuss how these may control leukocyte navigation strategies. In particular, we highlight our current knowledge on leukocyte navigation in complex chemoattractant fields and summarize them for three leukocyte subsets (neutrophils, T cells, and dendritic cells [DC] ) with different physiological trafficking paths. For each cell type, we will critically evaluate the relevance of current concepts for leukocyte navigation in mouse tissue. While it is very likely that some navigation strategies are only relevant for certain immune cell types and adapted to specific physiological tissue environments, leukocyte subsets may also share basic strategies for directional decision-making in lymphoid and inflamed tissues of mammals.
| Concepts and mechanisms of GPCR-controlled leukocyte navigation
Many chemokines and chemoattractants are classical inducers of leukocyte polarity, adhesion, and locomotion. They act through GPCRs on intracellular signaling pathways to establish biochemical asymmetry within the cell, preceding the formation of a polarized cell with an actin-rich front and a myosin II-rich rear. 12, 13 Key molecular pathways involved in establishing functional polarity downstream of GPCRs in leukocytes depend on phosphoinositide 3-kinases (PI3K) and members of the Rho family of small GTPases. 14 Rac isoforms, Cdc42 and
RhoA represent major signal hubs that act through several effector molecules to regulate actin polymerization and actomyosin cytoskeleton. The balanced interplay of these components shapes the typical amoeboid migration mode of each leukocyte subset. 15, 16 In homogeneous fields of soluble chemokines and chemoattractants, most leukocytes undergo self-polarization, before increasing their motility, migration speed, and movement in a random and undirected fashion (chemokinesis) ( Figure 1A ). 17 Chemokinesis is considered a migratory pattern that helps leukocytes scan large tissue volumes.
We have learnt from intravital microscopy studies in mice that lymphocytes show such continuous undirected (random-walk) migration in lymphoid organs to enable encounters and interactions with other leukocytes. 9 Together with other determining factors (eg, confinement between stromal tissue elements), uniform chemokine signals critically control chemokinesis by increasing the speed of randomly moving lymphocytes in situ. 18 Once leukocytes perceive external gradients of soluble chemokines and chemoattractants, they can perform directional movement along the concentration gradients of these diffusing attractants (chemotaxis) ( Figure 1B ). 17 Some leukocyte subsets have also been reported to be repelled from high chemoattractant concentrations (chemorepulsion), leading to their movement against the gradient (fugetaxis). 19 However, the underlying molecular mechanisms of this F I G U R E 1 General GPCR-controlled migration responses. (A) Homogeneous fields of soluble chemoattractants (chemokinesis) or surface-immobilized chemokines (haptokinesis) can induce leukocyte self-polarization and migration in a non-directed fashion. (B) Gradients of soluble chemoattractants (chemotaxis) or surface-immobilized chemokines (haptotaxis) can direct leukocytes toward higher attractant concentrations along the gradient. (C) Leukocytes have also been observed to perform directed migration against a chemoattractant gradient (chemorepulsion/fugetaxis) 6, 23 The terms "chemotaxis" and "haptotaxis" subsume a spectrum of navigation strategies, which leukocytes can use to follow attractant gradients. 24 When perceiving an external attractant gradient, some leukocytes (eg, unstimulated neutrophils in culture dish) undergo a full morphological change from unpolarized shape to the establishment of a front-back axis, which then leads to directional movement along the gradient. In contrast, other leukocytes already migrate with pre-established polarity (eg, DCs and neutrophils in 3D), before they steer along the gradient by redirecting their migration path. Alternatively, prepolarized leukocytes may move along a gradient without redirecting their path and start to accelerate the closer they get to the attractant source (eg, neutrophils in response to dying cells). Once at the highest attractant source, leukocytes may also actively decelerate and slow down their migration. 24 As evidenced from intravital microscopy of select leukocyte subsets, we know that this spectrum of chemotactic responses also occurs in mouse tissues. While we acknowledge that chemokines Are there inherent differences between leukocyte subsets in their navigation strategies?
As many other cell types, leukocytes possess several mechanisms that directly regulate the functionality of GPCRs. 13, [25] [26] [27] [28] and phosphoinositide-specific phospholipase Cβ (PLC)/inositoltrisphosphate (IP3)/diacylglycerol effector pathways. 29, 30 The termination of GPCR signaling relies on the intrinsic GTPase activity of the Gα subunit that hydrolyzes GTP and reassembles as Gα-GDP with Gβγ to form an inactive heterotrimer. This Gα GTPase reaction is accelerated by a family of proteins, called "regulators of G-protein signalling" (RGS proteins) to facilitate the rapid turning off GPCR signaling. Hence, RGS proteins are considered key desensitizers of G-protein-signaling pathways. 27 In addition, another negative feedback loop evolved to prevent the overstimulation of cells through excessive GPCR stimulation. Following agonist binding and G-protein activation, GPCRs become rapidly phosphorylated on their cytoplasmic tails and intracellular C-termini by specific enzymes, usually members of the GRK family. 31, 32 The pattern of receptor phosphorylation creates a barcode with high-affinity binding sites for the recruitment of β-arrestin proteins. 33 As a consequence, the increased binding of β-arrestin to the receptor sterically hinders the GPCR interaction with G-proteins. This uncoupling of G-proteins from the receptor, referred to as "receptor desensitization", prevents further GPCR activation by repeated agonist stimulation over seconds to minutes. 34 β-arrestins can also control more long-lasting desensitization of GPCRs over minutes to hours. As they can interact with clathrin-coated pits, their binding to GPCRs also targets receptors for internalization. Besides, GPCR internalization can also follow other pathways (arrestin independent, clathrin independent)
or not occur at all. 35 Depending on the intracellular trafficking route, the internalized receptors may be subject to degradation, leading to the downregulation of cell surface GPCRs. Alternatively, targeting internalized GPCR to recycling endosomes and back to the plasma membrane can quickly replenish GPCRs on the cell surface. 35 In addition to their important roles in receptor inactivation and internalization, GPCR-recruited β-arrestins also act as signaling mediators by directly coupling to numerous signaling molecules. 36 At many
GPCRs, β-arrestin-mediated signaling and classical G-protein signaling can have distinct biochemical and physiological actions from one another. A relatively new paradigm on GPCR signaling considers the allosteric interaction among the ligand, the GPCR, and the transducers (β-arrestins and GRKs) and how their contribution influences the bias for G-protein-or β-arrestin-mediated signaling. 28 Resulting from this paradigm, the concept of biased agonism, ie, that different ligands at the same GPCR are able to activate some signaling pathways while blocking others, is of particular interest for many chemokine receptors with prominent roles in leukocyte navigation. 37 In the following, we will point out the most commonly and recently discussed mechanisms, which would allow the control of leukocyte navigation. Given the before-mentioned regulation mechanisms for GPCR functionality, a "One-GPCR system" appears already sufficient to control chemokinesis and chemotaxis of leukocytes ( Figure 2A -E). To increase the sensitivity for attractant gradients, leukocytes can upregulate the cell surface expression of GPCRs. Some leukocytes store GPCRs in intracellular vesicles, which can fuse with the plasma membrane under conditions of leukocyte activation. 38 While the release of GPCR from vesicular stores occurs within minutes to hours, most leukocytes often respond to external stimuli by changing their cell surface GPCR profile over hours to days. These changes are primarily based on the induction of gene-transcription networks, which also include GPCR proteins, when leukocytes transition between cell states or undergo differentiation ( Figure 2A ). Multimerization of GPCRs, including homomerization of the same GPCR type, provides another level of GPCR regulation. 25 A recent study highlighted the functional importance of GPCR oligomerization in promoting leukocyte chemotaxis ( Figure 2B ). By lowering cellular cholesterol, inflammatory stimuli enabled GPCR oligomers that acted as scaffolds for distinct promigratory signaling pathways to foster efficient leukocyte migration. 39 However, GPCR multimerization has also been reported to dampen GPCR responsiveness. 25 Several other mechanisms can attenuate the sensitivity of leukocytes for chemokines and chemoattractants. One involves the presence of a receptor antagonist that binds to the same GPCR as the gradient-forming attractant agonist, but exerts blocking function for promigratory signaling ( Figure 2C ). More cell-intrinsic mechanisms include the downregulation of GPCR expression by lowering GPCR mRNA stability 40 or enhancing GPCR degradation. 41 As discussed above, agonist-induced receptor desensitization also attenuates the signaling responsiveness of GPCRs. Upon homologous desensitization, when GRKs phosphorylate agonist-specific GPCRs, the further recruitment of β-arrestins can lead to G-protein uncoupling and internalization of GPCRs ( Figure 2D ). This process explains why many leukocyte chemotaxis responses toward single attractants are dose dependent and follow a bell-shaped curve, with higher concentrations resulting in stasis. 42 Homologous desensitization may be particularly relevant when leukocytes sense high attractant concentration in situ, eg, at the center of an attractant source. 43 Under such conditions, the majority of cell surface
GPCRs is likely to undergo desensitization, internalization, and degradation, which may then result in cellular unresponsiveness to continuous or repeated stimulation through the same attractant.
As a strategy to remain responsive to subsequent stimulation in gradients, some leukocytes internalize GPCRs, deploy its ligand cargo into lysosomes, and quickly recycle unloaded GPCRs back to the plasma membrane. 44 Thus, by eliminating chemotactic factors from the extracellular environments, classic GPCRs can acquire additional scavenging function. This "consumption" of external attractant may also impact the chemotactic milieu by reducing the strength of attractant cues. 44 Instead of only binding one agonist, many "One-GPCR systems" can bind and respond to two or more chemoattractants and activate downstream signaling ( Figure 2E ).
Sensing these distinct attractants through the same GPCR in a spatial or temporal sequence can provide another navigation strategy.
In our body, leukocytes are rarely exposed to only one chemotactic factor. For efficient trafficking between organs and coordinated movement within tissues, most leukocytes express more than one GPCR on their surface and sense a wide range of chemokines regained momentum with the recent developments in fabricating microfluidic-based chemotaxis devices. We will now briefly summarize common mechanisms and concepts for leukocyte navigation, which become already relevant in the presence of a second GPCR signaling system ("Two-GPCR systems") ( Figure 3 ). As leukocytes often use combinations of more than two-GPCR systems, these principles could be further expanded. Step-by-step navigation through sequential chemotactic fields. When the two signals are spatially segregated, leukocytes first respond to signal 1 only, before maneuvering itself into a competitive situation with a second signal, as in (C). (F) Two-GPCR systems also include leukocytes co-expressing a signaling GPCR and non-signaling, scavenging GPCR for fine modulating the chemotactic response to one attractant agonist Figure 3A) . [45] [46] [47] [48] Under conditions when both attractant signals are oriented in the same direction and overlap, the two-GPCR signals have usually additive effects for leukocyte chemotaxis ( Figure 3B ). In the case of promigratory signals, chemotactic factors act often synergistically to improve chemotaxis along the same direction. 49 Physiologically, this might be of particular relevance for tissue sites where overlapping attractant gradients originate from the same local area. A special variant of GPCR signal synergism has initially been observed in migrating human and mouse neutrophil populations in vitro. During their chemotaxis in response to shallow N-formyl-peptides (fMLF) gradients, neutrophils released the lipid leukotriene B4 (LTB4) that acted on top of the early chemotactic factor as a signal relay molecule to improve chemotaxis of the whole neutrophil population. 50 Under conditions when leukocytes encounter two spatially opposing gradients, the two-GPCR signals compete for guiding leukocytes into one or the other direction ( Figures 3C and 4 ). Leukocytes exposed to two opposing attractants with equal signaling strength will likely accumulate and find migratory equilibrium in the middle of both gradients ( Figure 3C ). 47, 48, 51, 52 However, an unequal signaling input from both signals favors the movement of leukocytes into one direction ( Figure 4A ). 47 It is known for decades that specific GPCR signals can dominate over other GPCR signals, which enables leukocytes to prioritize some chemoattractant signals over others ( Figure 4B ). 42, 45 This aspect of GPCR crosstalk provided a first conceptual framework for neutrophils traveling in a stepwise fashion from the blood into infected tissues. 45 Initially, it was discussed that heterologous desensitization of GPCRs might be an underlying mechanism for prioritizing chemotactic cues. In contrast to homologous desensitization (see above), heterologous GPCR F I G U R E 4 Prioritizing G-proteincoupled receptor (GPCR) signals in opposing attractant gradients. Leukocytes exposed to two opposing signals with the same chemoattractive potencies will likely find migratory equilibrium in the middle of both gradients (Fig. 3C) Figure 4C ). In many physiological settings, leukocytes are thought to navigate step-by-step through sequential chemotactic fields.
Under conditions of two spatially segregated chemotactic signals in sequence ( Figure 3E ), leukocytes may first move along a first attractant gradient ( Figure 1A ), and then subsequently sense the gradient of a second, more distant attractant. During the transition from first to second attractant gradient leukocytes then encounter a competitive situation between two gradients ( Figure 3C ). When the second signal is dominant over the first one, it is plausible that leukocytes are recruited to and then retained at the distant site.
Importantly, even without any dominance between the signals, leukocytes can migrate away from a first attractant and travel toward a second, more distant attractant. 45 In principle, this also allows leukocytes to leave chemotactic fields of high, saturating concen- ACKRs acting as rheostats in restricting excessive migration in response to moderate chemokine levels ( Figure 3F ).
56-58
As we have just outlined, leukocytes have evolved several molecular mechanisms that allow an enormous spectrum of GPCRcontrolled navigation strategies. Many of the emerging concepts for leukocyte navigation in complex chemoattractant fields have been developed in controlled in vitro systems, some of which by studying only one select leukocyte subset. Rigorous testing and proving the relevance of these concepts for leukocyte migration in the complexity of mammalian organs and tissues is technically very challenging. However, systematic studies in mice have started to delineate GPCR-controlled navigation strategies and their influence on physiological trafficking patterns through lymphoid organs and inflamed peripheral tissues. In the following, we will discuss our current knowledge on the role of GPCR signals for the migration patterns of three leukocyte subsets (neutrophils, T cells, and DCs). Each of these immune cell types has evolved their own trafficking paths to fit their effector functions. We will highlight recent studies that conceptually advanced our understanding of GPCR-controlled leukocyte navigation in mammalian tissues.
| NEUTROPHIL S
Neutrophils are pivotal effector cells of our innate immune response and the first line of defense for eliminating bacteria and fungi in tissues. 59 Recent studies also implicate regulatory functions of neutrophils in tissue homeostasis and cancer. 60 In mammals, they are produced in the bone marrow and are continuously released into the bloodstream to patrol the intravascular compartment under homeostasis. Neutrophils circulate in the blood for ca. 12 hours under the influence of circadian rhythms, before they are mostly cleared into the bone marrow, but also other extramedullary tissues. 61 In contrast to the general believe that naive peripheral tissues are free of neutrophils, recent work suggests that low numbers of neutrophils are present in many tissues under steady state. 62 Upon inflammation and infection, the release of neutrophils from bone marrow increases their concentration in the blood by several folds. rially by the array of GPCRs they express and by the sequence of chemoattractant gradients they encounter ( Figure 3E ). 45 In this concept, pathogen-derived "end-target" chemoattractants (N-formyl peptides, C5a) will dominate over host tissue-derived "intermediate- . 50, 74 This paracrine signaling mechanism becomes very relevant in chemotaxing neutrophil populations. Neutrophil-released LTB4 functions as a signal relay molecule and amplifies in a feed-forward manner the chemotactic response to subsaturating concentrations of end-target attractants ( Figure 3B ). 50, 75 Recent developments in microfabricated devices and microfluidic-based chemotaxis systems now allow a more detailed analysis of neutrophil migration responses in complex chemoattractant milieus, providing deeper insight into neutrophil navigation in opposing gradients ( Figure 3C ), 47, 73, [76] [77] [78] synergistic gradients ( Figure 3B ), 49 and geometrically complex environments. 49, 77 Moreover, even the analysis of GPCR signaling underlying neutrophil swarming dynamics is now possible due to novel micropatterning techniques. 75 As human PMNs, mouse neutrophils express a range of functional GPCRs to sense N-formyl peptides (through FPR1 and FPR2), C5a (mainly through C5ar1), LTB4 (mainly through LTB4R1/BLT1), and several chemokines including CXCL1, CXCL2, CXCL5 (through CXCR2), CXCL12 (through CXCR4), and several CC-chemokines (through CCR1). 67 Some of these GPCRs are present in secretory vesicles that can rapidly fuse with the plasma membrane upon neutrophil activation, allowing the cells to increase their responsiveness to chemotactic cues ( Figure 2A ). 38 Other reported mechanisms to control GPCR functionality in neutrophils include competitive antagonism or partial agonism ( Figure 2C ), 79 receptor multimerization ( Figure 2B ), differential agonist responses ( Figure 2E ), 80 and agonist scavenging through simultaneous expression of ACKRs ( Figure 3F ). 56 Homologous desensitization is a wellknown phenomenon for almost all neutrophil-expressed GPCRs Intravital microscopy studies of GPCR-deficient neutrophils provided novel insight into how GPCR signals choreograph the physiological trafficking paths of neutrophils. In the following, we will point out that GPCR signals are important throughout many steps in the lifecycle of a neutrophil. In particular, we will highlight studies that advanced our concepts of GPCR-controlled neutrophil navigation in mouse tissues.
| Bone marrow release: inhibiting chemokine-mediated retention
The majority of mature neutrophils in the body reside in the bone marrow, with an estimated ratio of 300:1 between neutrophils in the bone marrow and blood. Neutrophil release into the blood is controlled by the interplay of retention and mobilization signals, provided by two antagonistically operating chemokine systems ( Figure 3A ,C). During homeostasis, the chemokine CXCL12 is produced in the bone marrow and essential for the retention of mature neutrophils that express the corresponding chemokine receptor CXCR4. 90 CXCL12 is expressed at highest levels by "CXCL12-abundant reticular cells" (CAR cells), but also by other stromal cells of the bone marrow, including osteoblasts. 63, 91 The expression levels of CXCL12 in stromal cells follow a circadian rhythm, controlled by the sympathetic nervous system. 92 When neutrophils were freshly isolated from the bone marrow, they expressed only low levels of cell surface CXCR4, but contained high intracellular levels of CXCR4. 90, 93 After placing these cells in medium lacking CXCL12, they upregulated cell surface CXCR4 within hours. 90, 93 These findings suggested receptor desensitization and internalization in response to constitutively high local concentrations of CXCL12 in the bone marrow microenvironment ( Figure 2D ). Moreover, these data underlined that neutrophils receive constant CXCL12 signals, which position them in the bone marrow, probably by activating integrinmediated adhesion to stromal cells. 94 While high concentrations of CXCL12 retain neutrophils in the bone marrow via CXCR4 signaling, low concentrations of CXCR2 ligands expressed on endothelial cells and produced by megakaryocytes facilitate neutrophil egress via CXCR2. 63 Thus, CXCR2 signals recruit neutrophils out of the retentive CXCL12 field and direct them to the endothelial sinus walls for entry into the blood circulation ( Figure 3A ). This intricately balanced interplay between retention and mobilization signals can be shifted in both directions. G-CSF treatment or acute inflammation, which increases blood serum levels of G-CSF and CXCR2 ligands, shifts the balance toward neutrophil mobilization from the bone marrow. [95] [96] [97] [98] Several modes of action have been proposed for G-CSF, either leading to the lowering of CXCL12 levels in the bone marrow or triggering the release of CXCR2 ligands from endothelial cells or megakaryocytes (summarized in 63 ). The same shift toward neutrophil egress can be achieved by conditional gene depletions of CXCR4 or CXCL12 in mice. 99, 100 The administration of the CXCR4 antagonist AMD3100 also results in a threefold increase in the number of circulating neutrophils and a corresponding decrease in bone marrow numbers. 93, 101 Originally, this drug effect was interpreted as direct antagonism of CXCR4 expressed by neutrophils, thereby disrupting the CXCL12-CXCR4 axis in the bone marrow ( Figure 2C ). 90 Surprisingly, subsequent studies found that AMD3100 also acted on CXCR4 expressed by bone marrow endothelial cells, and inhibited the translocation of CXCL12 across bone marrow endothelial cells, suggesting a rapid rise of CXCL12 in the blood and reversal of the CXCL12 gradient ( Figure 3B) . 102, 103 These data were questioned by intravital imaging studies that could not observe clear neutrophil egress from the bone marrow upon AMD3100 treatment. Instead, the increase in circulating neutrophils through AMD3100 was explained by the release of marginated neutrophils from the lung microvasculature. 104 Moreover, AMD3100 had a blocking effect on the trafficking of aged blood neutrophils, which upregulate CXCR4 expression over time, enabling them to home back to the bone marrow for clearance. 104 The exact mode of action of AMD3100 is still controversially discussed. Figure 1B ). There are ample references to support the common believe that chemotactic gradients between the apical and basolateral part of postcapillary venules promote diapedesis, ie, the outward passage of neutrophils through the vessel wall. Immunofluorescence stainings of HS GAG moieties revealed steep gradient of HS GAG scaffolds between the luminal and abluminal aspect of skin postcapillary venules. 119 Under inflammatory conditions, HS GAG distribution became even more polarized by massive depositions of HS and laminin in the basolateral basement membrane of skin vessels. 119 Given the GAG-binding properties of many chemokines, it was proposed that these sharp HS GAG scaffold gradients might favor chemokine gradients across the venular wall. In agreement with this idea, excessive deposition of the GAG-binding chemokine CXCL1 on the apical part of inflamed blood vessels resulted in decreased neutrophil diapedesis. 120 Other supporting data come from experiments in which an extravascular source of CXCR2 ligands was placed in form of a gel on one side of a blood vessel. 121 Under these conditions, neutrophil crawling was directed to emigrate preferentially from that side of the vessel. HS GAG on the surface of the endothelium was required to present CXCL2, forming a chemotactic gradient that was followed by neutrophils.
This sequestration of endothelial chemokine occurred exclusively in venules, but not other blood vessel types. 121 HS GAG, together with the atypical receptor ACKR1, was also discussed to establish gradients by transcytosis of chemokines. Figure 3E ). 74, [128] [129] [130] [131] While it has long been known that immune complexes lead to the activation of the alternative complement system in arthritis, 132, 133 it has only recently been found that C5aR signaling in circulating neutrophils is the key initiator for a cascade of events that ignite inflammation. albicans by neutrophils depended on complement-mediated chemotaxis. 134 In addition, complement activation stimulated neutrophils to secrete LTB4, which amplified the directional recruitment and clustering of neutrophils in a synergistic manner ( Figure 3B ). This was in agreement with a previous study highlighting the importance of LTB4-mediated signal amplification during neutrophil swarming in interstitial tissue spaces at sites of sterile skin injury and in bacteria-infected lymph nodes. 135 Neutrophil swarming is an essential process of the neutrophil tissue response and has been observed in diverse tissues under conditions of sterile inflammation and infection with various pathogens, including bacteria, fungi, and parasites. 65, 66 The swarming response comprises sequential phases of highly coordinated chemotaxis followed by neutrophil accumulation and the formation of substantial neutrophil clusters, which has led to the multistep attraction model of neutrophil swarming. 66 While the underlying signals and molecular players for some of these steps are still unclear, we know that neutrophil-derived LTB4 acted on top of early released, yet unknown, chemoattractants and mediates intercellular signal relay among neutrophils to amplify interstitial recruitment in a feed-forward manner ( Figure 3B ). This model was in accordance with earlier in vitro studies identifying LTB4 acted as a signal relay molecule (see above). 50 As a consequence, LTB4-LTB4R1
signaling enhances the radius of neutrophil recruitment from distant tissue sites and maintains the amplified chemotactic response of the neutrophil population. Together with signaling through other GPCRs, such as CXCR2 and FPR2, LTB4R1 signaling also optimizes neutrophil clustering. 135 Importantly, LTB4 and CXCR2 signals are also relevant for the swarming response of human neutrophils. 75 The formation of focalized dense neutrophil aggregates is considered beneficial for isolating sites of tissue wounding from viable surrounding tissue, containing microbial invaders and concentrating the microbicidal activity of a whole neutrophil population in one swarm center. 66 However, neutrophil aggregation can also lead to tissue damage and removal of other cells. 135, 136 In the context of the lung microvasculature, intravascular neutrophil swarms that formed in response to C. albicans infection lead to vessel occlusion and pulmonary hemorrhages, which were reverted in the absence of LTB4R1. 134 How neutrophil-derived LTB4 shapes and maintains a promigratory chemotactic field in vivo remains unclear. LTB4 is considered to have a short half-life and can be rapidly turned into LTB4 metabolites, which act as natural inhibitors of LTB4-mediated responses. However, it has also been demonstrated that neutrophils release LTB4 in form of exosomes, which may support more prolonged effects of LTB4 gradients. 137 Interesting insights into this issue come from studies with diabetic mice receiving skin infections with methicillin-resistant Staphylococcus aureus (MRSA), which leads to large neutrophil clusters in form of abscesses. 138 Diabetic mice produce higher levels of LTB4 in the infected skin compared to non-diabetic mice. Surprisingly, neutrophils in the skin of these mice failed to assemble into an organized abscess, as excessive LTB4 levels likely disrupted chemoattractant gradients in the skin and impaired directed neutrophil chemotaxis. 138 These findings exemplify that the appearance or absence of neutrophil swarms depends on the specific mixture of chemoattractants in a specific inflammatory environment.
Although not yet studied in detail, we know that several factors, including tissue damage size, presence of pathogens, induction of cell death, and neutrophil numbers, are important for shaping the exact neutrophil-swarm phenotype in an inflamed tissue. All these factors can potentially initiate the release of chemotactic fields that may strengthen or attenuate LTB4-mediated signal amplification in situ. 66 
| Getting to the site of inflammation: following hierarchies
True prioritization of chemoattractant fields has been observed for neutrophils in a model of thermal-induced liver injury. 139 In this model, large numbers of neutrophils are recruited over hours from the liver sinusoids to a focal site of sterile hepatic necrosis. The necrotic area releases several molecules that shape the adjacent hepatic environment and ultimately form two distinct chemotactic fields at different distances from the necrotic focus. During their search for damaged tissue neutrophils sequentially navigate through these two chemotactic fields. First, neutrophils follow an intravascular gradient of GAG-bound immobilized CXCL2 that supports integrin-dependent crawling toward the necrotic focus. This CXCL2 haptotactic gradient abruptly halts, approximately 150 μm proximal to the border of the necrotic tissue. Second, neutrophils at this border continue to migrate on top of platelets along non-perfused vasculature, before entering the necrotic area. 139, 140 When neutrophils were lacking the formyl-peptide receptor FPR1, they migrated along the healthy sinusoids to the highest concentration at the end of the haptotactic CXCL12 gradient and never entered into the plateletrich and following necrotic zone. Given the important role of FPR1 signaling during this process, mitochondrial-derived formyl peptides released from dying hepatocytes were suggested to attract neutrophils into the necrotic area. Of interest, FPR1 signaling has also been shown to regulate neutrophil recruitment into necrotic areas of hepatic ischemia-reperfusion injury. 141 In contrast to formyl peptides released from bacteria, endogenous formyl peptides are produced by mitochondria and become released upon cellular damage. 142 Similar to bacterial formyl peptides, also mitochondrial formyl peptides can promote neutrophil chemotaxis in an FPR-dependent manner. 139, 142 Thus, neutrophil navigation in the liver injury model follows a spatial cascade of chemoattractants ( Figure 3E ) and appears to depend on the prioritization of an end-target attractant (eg, fMLF) over an intermediate-target attractant (eg, CXCL2) ( Figure 3A) . Recent elegant work by Kubes and colleagues revealed that neutrophils play a critical role in fully repairing the hepatic injury. In the course of this process, neutrophils at the border of the injury left the injury site and reentered healthy liver sinusoids. 143 However, it remains to be shown if GPCR-controlled mechanisms are involved in this form of reverse migration into the vasculature. In vitro experiments to address how lymphocytes respond to chemokines were primarily based on transwell, under agarose assays or 3D ECM-like gels, showing that chemokinesis, chemotaxis, and homologous and heterologous desensitization apply to GPCRmediated navigation of T cells. [144] [145] [146] [147] [148] [149] However, these approaches have limitations when trying to address how T cells respond to more complex chemokine fields involving multiple GPCRs. With the development of microfluidic devices 150 and more recently, microfluidic mazes, T-cell exploratory patterns and chemotaxis in response to chemokines could be analyzed in more detail, while providing the investigator with a higher level of control and precision. 151 Overall, however, there are only a few studies that have addressed complex
| T CELL S

GPCR interactions in T cells in vitro. In the following sections we will
focus on what we have learned from in vivo experiments regarding the trafficking of T cells.
| Searching for the antigen: exploration and compartmentalization
In vivo, chemo-and haptokinesis are particularly prevalent in lymphoid organs and underlie the continuous undirected or randomwalk migratory activity of lymphocytes ( Figure 1A ). 9 Functionally, this migratory behavior is required to enable encounters and consecutive interactions between leukocytes. In other words it reflects the search strategy of lymphocytes to detect rare interaction partners in a large and densely populated three-dimensional space. Given the low precursor frequency of lymphocytes, such migratory behavior was predictable; yet direct visualization of lymphocyte migration by means of intravital two-photon microscopy fundamentally changed our perception how lymphocytes navigate and interact with their environment in complex tissues. 8, 152 This migratory behavior of T cells in vivo is regulated by several factors (for review see 153 ). In the steady state T-cell subset distribution within the LN or the white pulp of the spleen is inhomogeneous. For example, it has been observed that the localization between CD4 and CD8 lymphocytes in the white pulp of the spleen is not fully overlapping. 166 Specifically, CD8 T lymphocytes populate more densely the deep paracortex, while CD4 T lymphocytes are located in slightly more peripheral areas of the white pulp or the LN paracortex, respectively.
Gpr183-mediated chemotaxis is likely the basis for this differential localization. CD4 T cells express significantly higher levels of Gpr183 than CD8 T cells and the ligands for Gpr183, oxysterols, are emitted at the interfollicular area (and the bridging channel of the spleen).
Reminiscent to the differential localization of T lymphocytes, oxysterols regulate the localization of cDC2 in contrast to cDC1 that are more abundant in the deep paracortex. [167] [168] [169] However, in principle, differential localization in the SLO may also be explained via the engagement of another GPCR in particular CCR7. The peculiarity of SLO compared to other organs is that the majority of its cellular elements (lymphocytes) are constantly in motion in a chemokinetic manner as discussed above. Therefore, in principle in a 3D-space, which is homogenously populated by a heterogeneous group of cells, relocalization of one group of cells could be either active or passive to enter the B-cell follicle as a second step. 173 Consistently, FRC (fibroblastic reticular cells) at the T/B border produces less CCL19 than their counterparts in the paracortex. 174 Similarly, we observed that memory CD8 T cells express lower levels of CCR7 and are located at peripheral areas of the LN paracortex. By contrast to naive CD8 T cells that express higher levels of CCR7 and populate the deep paracortex. 170 So memory CD8 T cells may in part be displaced (crowding out) from the deep paracortex by naive CD8 T cells that experience a stronger chemotactic attraction to this area.
Chemotaxis not only regulates the localization of conventional T cells but also navigates NK cells and invariant T cells in SLO.
Functionally, these lymphocytes are localized in closer proximity to lymphatic sinuses in order to promote a more rapid response against lymph-borne pathogens, which is essential to avoid microbial dissemination. 175, 176 Invariant T cells are attracted to SCS via CCL20-CCR6-mediated chemotaxis. 
| Recirculation: modulation of sensitivity
Homologous receptor desensitization as a means to regulate GPCR signaling is a well-established concept in vitro ( Figure 2D ). In particular, chemokine receptor internalization on T cells has been demonstrated for CXCR4, CCR7, CCR5, and CXCR3. [145] [146] [147] [148] In vivo, CXCR3 also gets rapidly internalized on memory CD8 T cells upon ligand exposure in the context of viral infections. 171 However, to what level CXCR3 desensitization modulates T-cell migration in vivo during inflammatory conditions and how this contributes to pathogen resistance remains largely unknown. Probably the best established example for the physiological relevance of receptor desensitization is S1PR1. S1PR1 is essential for the exit of lymphocytes from SLO and the thymus. 180 The ligand S1P is expressed by hematopoietic cells, in particular erythrocytes leading to high concentration in the blood. In order to generate a gradient, tissue expressed S1P lyases efficiently degrade S1P, thereby reducing its concentration in tissues. T cells express high levels of S1PR1 on their surface, but once they enter the blood stream, S1PR1 is rapidly down modulated, promoting Tcell entry into SLO. 181 Within SLO, S1P concentrations are low, leading to re-expression of S1PR1 on the cell surface and lymphocytes regain the ability to exit SLO over time (for review 182 ). Added to the cyclic surface expression pattern of S1PR1, also CCR7 surface expression appears to undergo a periodic pattern. In particular, it was found that CCL19 leads to receptor occupation and internalization of CCR7, functionally impairing its responsiveness in vitro. 183 So how is GPCR desensitization regulated in T cells? Regarding S1PR1 desensitization the kinase GRK2 plays a central part. 185 Notably, GRK2 also regulates the desensitization of other chemokine receptors like CCR5 in T cells. 186 During chronic inflammatory conditions in humans, GRK2 expression levels appear to be significantly reduced on T cells supporting the notion that GRK2-mediated GPCR desensitization plays an important role in T-cell trafficking beyond recirculation. Counterintuitively, absence of GRK6, which is also highly expressed in T cells, strongly impairs CXCR4-mediated chemotaxis toward CXCL12 in vitro. This shows that
GRKs work is a more complex fashion that likely goes beyond GPCR desensitization. 187 Besides GRKs, a large group of RGS proteins is known to regulate GPCR signaling in lymphocytes. 188 Several RGS proteins are highly expressed in lymphocytes. However, so far only RGS1 deficiency revealed a definitive role of these proteins in lymphocyte migration in vivo. Specifically, RGS1 reduces the sensitivity toward CXCR4
and CCR7 ligands, 189 and in particular regulates the trafficking and residency of T cells in the gut. 190 Additionally, Trm show a significant upregulation of RGS1 compared to Tcm arguing for a more general function of this protein in regulating tissue residency of T lymphocytes. 191 Changes in sensitivity toward a GPCR ligand can also be modulated by changes in GPCR expression levels ( Figure 2A ). In T cells dynamic changes in GPCR surface expression is tightly connected to their biological function. We will discuss this in detail below as this involves multiple GPCRs. A special case is periodic changes in GPCR expression on lymphocytes in the context of the circadian rhythm.
These changes modulate the recirculation and migration pattern of lymphocytes and myeloid cells and therefore have a profound impact on both innate and adaptive immune responses. 192, 193 This has been excellently reviewed elsewhere 194 and will not be further discussed here.
In summary, there is robust in vivo evidence for the importance of GPCR desensitization regarding T-cell recirculation, yet to what level this mechanism regulates T-cell trafficking toward inflammatory F I G U R E 6 Time-dependent changes in G-protein-coupled receptor (GPCRs) during activation of CD8 T cells. Evolution of the GPCR expression pattern of CD8 T cells after activation. The GPCR expression pattern of naive T cells (before activation) determines their search behavior for antigen-presenting DC. GPCRs expressed between d1 and d3 may help activate T cells to support their differentiation by promoting encounters with specific DC or by navigating them into distinct inflammatory environments within SLO (eg, toward licensed cDC1 that relay CD4-helper signals). GPCRs expressed during the effector phase help differentiated CD8 T cells to find target cells within infected tissues. GPCRs expressed in the memory phase determine the area of surveillance. Notably, the relative gene expression is shown on a population level, yet is highly heterogeneous or bimodal on a single cell level Time after CD8 T cell activation
chemokines in the context of infections still needs to be addressed in the future.
| Development and differentiation: it is (almost) all about time and space
Time-dependent changes in GPCR expression levels can be typically seen during development of cells and organs, but also during acti- processes called positive and negative selection. 195 Importantly, the functional development and instruction of thymocytes to mature lymphocytes is reflected by a physical journey of these cells through the thymus. During this "round-trip" thymocytes start at the corticomedullary junction, move to the thymic cortex and the subcapsular zone and then back to the cortico-medullary junction and the thymic medulla. 196 From here, mature thymocytes exit the thymus via S1P-S1PR1 signals and commence their GPCR-dependent recirculation between the blood and SLO. 197, 198 Likewise, the migration within the thymus is dependent of the timed expression of chemokine receptors in particular CXCR4, CCR7, and CCR9. 196 CCR7 signals contribute to thymocyte transition from the cortico-medullary junction to the outer cortex 199 and are critical for their migration back to the medulla. 200 Specifically CCL21Ser (and not CCL21Leu or CCL19) is the critical ligand for transition to the medulla and tolerance induction in T cells. 201, 202 CCR7 also cooperates with CXCR4 signals that mediate the migration to the thymic cortex 203 while CCR9 plays a nonredundant role for the transition from the cortex to the subcapsular area. 204 The differential role of these chemokine receptors during the migrational steps of thymocytes is reflected by their dynamic expression pattern during the developmental stages (Figure 2A ). 205 Vice versa blocking the migration of thymocytes in turn alters the development of the thymus and its functional organization. 196 After leaving the thymus T cells commence their recirculation between SLO that is regulated by S1PR1 as discussed above.
However, on the second look it becomes clear that multiple GPCRs are involved in this process that act in an opposing fashion. Once T cells enter the LN they stay for about 6-24 hours depending on the cell type-CD4 T cells dwell shorter than CD8 T cells, and Tcm longer than naive T cells. 206, 207 As mentioned above, time-dependent resensitization of S1PR1 in SLO promotes the exit to the lymph over time. Interestingly, CCR7 heterozygous lymphocytes have shortened dwell times in the LN, while CCR7 overexpressing or S1PR1
heterozygous T cells stayed significantly longer. 208 This argues for a competitive situation between retentions signals (via CCR7 and CXCR4) and exit cues (via S1PR1) that determine overall T-cell dwell times in LNs ( Figures 3C and 4 niches. 217, 218 In order to do so, they partially adopt the transcriptional programs of their respective T-helper cell counterparts. [219] [220] [221] Overall, temporal and spatial control of GPCR signaling in T cells is critical on two levels: (a) it guides their differentiation in SLO and (b)
it directs them to and within inflamed tissues where they execute their specific functions ( Figure 3E ). In the following paragraph we will focus on cytotoxic CD8 T cells, how their chemokine expression pattern changes during activation, in which way it differs among CD8 T cells subsets, and how it impacts on their differentiation.
Once naive CD8 T cells exit the thymus they commence their recirculation pattern through the body predominantly via the GPCRs CXCR4, CCR7, and S1PR1 as discussed above. Additionally and by contrast to naive CD4 T cells, naive CD8 T cells express high levels of CCR9 222, 223 and intermediate levels of CXCR6. 224 To date, the exact function of these chemokine receptors on naive CD8 T cells remains unknown. Upon activation, CD8 T cells change their GPCR repertoire. During their differentiation into effector and memory subsets specific GPCR patterns are established over time ( Figure 6 ). Accordingly, we can group different GPCRs based on their temporal expression pattern. We can further discern four phases during which GPCRs execute specific biological functions. Before activation, the time frame after activation but before T cells commence proliferation, T-cell effector phase, and T-cell memory phase. Naive T cells express GPCRs that are important for their recirculation but additionally may help them to efficiently detect antigen-presenting DC.
In particular, CXCR6, Gpr183 (Ebi2), and CCR9 could support this process. Once a CD8 T cell has engaged an antigen-presenting DC it co-arrests and interacts with it for several hours. [225] [226] [227] [228] This activa- We and others have shown that in particular cDC1 relay these helper signals and are located in deeper paracortical areas. 169, 229, 233 By contrast CXCR3 appears to guide CD8 T cells to the subcapsular sinus of the lymph node and promotes effector T-cell generation. 170, 171, 234, 235 How activated CD8 T cells navigate within inflamed tissues (including the lymph node) through complex chemokine fields and in which situations CCR5-and CXCR3-mediated signals are rather synergistic than conflicting remains largely unknown. 236, 237 By the time that T cells have fully adopted their effector program and leave the lymph node they express additional inflammatory chemokine receptors like CCR2 and CX3CR1. While CXCR3 and CCR5 are expressed by the majority of CD8 T cells at the peak of an immune response, CX3CR1 shows a bimodal expression pattern with about half of the CD8 T cells expressing this GPCR.
Interestingly, the expression pattern of CX3CR1 strictly correlates with cytotoxic effector molecules like Prf1 and GrzmB. 238, 239 Importantly, CX3CR1 expression not only correlates with a specific effector function but also delineates a specific migratory behavior. It was recently shown that CX3CR1 hi effector memory CD8
T cells predominantly scan blood vessels rather than migrating within specific tissues with the exception of the spleen. By contrast, CX3CR1 int memory CD8 T cells that have been termed Tpm (peripheral memory T cells) appear to migrate through peripheral tissues and enter lymph nodes via afferent lymphatics rather than HEV. 240 GPCRs that help T cells to extravasate into inflamed tissues often act in a redundant manner while in other cases they work synergistically ( Figure 3B ). Typically, one chemokine receptor can bind to multiple ligands and vice versa one ligand can be bound by multiple receptors. 241 In GPCRs that may act in synergy or in antagonism is highly complex and is largely unknown.
| DENDRITI C CELL S
Conventional DCs (cDC) may be regarded as central inducers of adaptive cellular immune responses. DC express a variety of receptors that allow them to sense infections, cellular damage, and metabolic changes. [244] [245] [246] Additionally, as phagocytes, DC are able to take up antigen, digest and process it so that it becomes detectable for T lymphocytes in the context of MHC molecules. 247 Reflective of these biological functions, DC are able to integrate inflammatory and antigenic information and translate them into appropriate output signals which initiate a suitable immune response. 248 With regard to GPCR-mediated navigation a key feature of DCs is their migration from peripheral tissues to draining LNs in the context of their functional maturation. 249 In contrast to T cells which are geared to search large tissue volumes, DC need to migrate and to settle within specific anatomical niches of SLO in order to be efficiently encountered by T cells or to be strategically positioned for optimal access to antigenic material. 250 In mice and humans, DC comprise a rather heterogenous group of cells with differential localization in tissues, different migratory behavior, and functional specialization.
We currently discern four major groups of DC, 251 cDC that are further subdivided in cDC1 and cDC2, plasmacytoid DC (pDC) that are characterized by their ability to produce large amounts of IFNI allowing them to support both innate and adaptive immune responses, 252 and monocyte-derived DC (MoDC) that play a critical role during bacterial infections and coordinate effector responses in tissues. 253 Monocytes can differentiate into DC on-site following their immigration into inflamed tissues, yet their exact function regarding the development of adaptive immune responses is still under debate. 254 Overall, in order to fulfill their central function in lymphocyte activation, GPCR mediated navigation is a critical requirement for DC.
In vitro assays have been widely used to study DC migration in order to measure their responsiveness toward specific chemoattractants, to determine downstream signaling events and to identify critical molecules that are involved in DC locomotion. 16, 255, 256 and CCL21, which differ structurally. 258 CCL21 harbors a unique extended C-terminal tail that is negatively charged due to stretches of basic amino acids. This allows CCL21 to bind and become immobilized to GAG with high affinity, with the potential to form haptotactic gradients. 6 In contrast, CCL19 lacks this C-terminus and is hence considered to diffuse and form soluble chemotactic gradients.
In comparison, CCL21 can form steeper gradients than CCL19. 259 Transferring the CCL21 tail to CCL19 increases GAG binding of CCL19, 260 whereas CCL21 becomes more soluble upon removal of its C-terminus. 261 Interestingly, DC themselves can proteolytically cleave CCL21 to remove its C-tail, turning it into a more diffusible chemotactic molecule. 46, 261 Besides these differences in gradient formation, it is now also acknowledged that CCL19 and CCL21 bias CCR7 downstream signaling, desensitization, and receptor dynamics in distinct ways. [262] [263] [264] [265] Thus, these aspects of CCR7 functionality have received much attention and spawned the development of various in vitro assays, now allowing the analysis of DC migration in various experimental settings including 3D gels with soluble gradients of altered shapes, 256, [266] [267] [268] substrate-bound gradients, 269 or combinations thereof. 270 DC navigation in the presence of multiple chemotactic cues mostly focused on competing fields of CCL19 and CCL21. 46, 52, 270, 271 From one of such studies emerged the concept that local soluble CCL19 gradients can direct DC haptokinesis on immobilized CCL21. 46 In addition to CCR7, other GPCRs including CXCR4 52, 272, 273 and S1P receptors 274 are also functionally relevant for DC migration. When chemoattractive potencies were matched, DCs were found to home to central regions in opposing gradients of the CXCR4 ligand CXCL12 and CCR7 ligands. 52 In the following,
we will discuss what we have learned from in vivo studies regarding GPCR-guided DC navigation.
| Interstitial dynamics: from sessile networks to highly directed pathfinders
In contrast to lymphocytes, chemokinesis appears to play a minor role for the migration of cDC in the steady state ( Figure 1A) . cDC rather form a sessile network 275 in the lymph node, while newly arriving DC immigrants from the blood or the lymphatics are rapidly directed to their respective niche by chemo-and haptotactic signals ( Figure 1B) . However, there are some notable exceptions like CCR6-mediated chemokinesis that leads to the accumulation of cDC around small airways in the lung in the context of inflammation. 276 With regards to their steady-state migration but also their morphology, pDC represent a somewhat intermediate cell type between lymphocytes and cDC. In LNs, pDC migrate in a chemokinetic manner similar to lymphocytes albeit at a significantly reduced speed (5μm/ min) and with less spatial displacement over time. 172 The molecules that regulate LN entry and chemokinetic pDC migration in vivo are CCR7 and CXCR4. 277, 278 The first direct evidence for haptotaxis in guiding leukocyte migration in situ was provided in the context of cDC intravasation into lymphatic vessels ( Figure 1B) . 6, 279 Sixt and coworkers directly visualized CCL21 in ear skin whole mounts and showed that it forms steep gradients around lymphatic vessels. Cells with a sufficient size (like cDC) are able to spatially sense such gradients and migrate directionally toward lymphatic vessels. Importantly, CCL21
is physically attached to the ECM via binding to heparan sulfates and removal via heparitinase altered CCL21 patterning and diminished cDC migration. As almost all chemokines have GAG-binding properties, haptotaxis might be a more generally utilized principle for immune cell migration and in particular for cDC. For example, once DC intravasated into the lymphatic vessel, they follow a lymphflow induced haptotactic CCL21 gradient until they detach and get passively carried to the dLN. 280 When cDC arrive in the dLN they likely follow CCR7-mediated haptotactic cues in order to enter the LN parenchyma. 281 In line with this notion expression of the atypical chemokine receptor ACKR4 within the lymphatic endothelium has been shown to be critical to shape a CCL21 gradient across the sinus floor. 7 In the absence of ACKR4 migratory DC get trapped within the SCS and fail to enter the LN parenchyma. Haptotactic cues are probably not only guiding cDC to the LN but also help them to find their specific niche within SLO. However, this intranodal trafficking of cDC may also be a combination of haptokinetic and chemotactic signals as we will discuss in more detail below.
| Orientation in the tissue: Is it all about CCR7 functionality?
In general, cDC immigrate to LNs via two separate entry points. In the steady state DC undergo a complex maturation program that largely overlaps with pathogen-induced maturation. 283 This homeostatic maturation of DC is operative in the absence of microbiota or IFN I signaling, but depends on NF-kB activation. 284 A central element of the maturation process is the upregulation of CCR7. 285, 286 Figure 2D ). Homologous desensitization for CCR7 that is highly relevant for DC trafficking has been shown to be ligand dependent. In the case of CCL19, both GRK3 and GRK6 are activated leading to CCR7 internalization and recycling and overall to receptor desensitization. 263, 291 By contrast CCL21 only activates GRK6 and does not induce receptor internalization arguing for an alternative way of CCR7 desensitization. 265 In vitro, GRK6-deficient DC failed to migrate toward haptotactic cues in particular at low CCL21 concentrations. In vivo, the situation is less clear. While fewer GRK6-deficient DC are able to immigrate into ear skin explants than WT DC, these KO DC intravasated more efficiently into the lymphatic vessels.
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Upon GRK-mediated phosphorylation of the GPCR, arrestins get recruited initiating the actual desensitization process. 292 In particular, β-arrestin 2 has been shown to regulate the sensitivity toward CCR7 and CXCR4 mediated cues. Functionally, β-arrestin 2 deficiency in DC resulted in enhanced steady-state migration to SLO and aggravated disease status in various autoimmune models. 293 On a molecular level, β-arrestins, like GRKs seem to act beyond receptor desensitization leading to more complex phenotypes that cannot be explained by alterations in migratory behavior alone.
In summary, modification of GPCR surface expression and sensitivity regulation are integral elements of DC migration and function, allowing them to mount and fine-tune adaptive immunity toward infections via compartmentalization of leukocyte interactions. 294 As discussed above, the migration of DC from tissues to the dLN is a process that is dominated by CCR7-mediated guidance cues. But not only CCR7 is dominant as a receptor also regarding its ligands CCL19 and CCL21 there is a clear hierarchy in vivo. In particular, it was shown that CCL19-deficient animals show normal DC migration to and localization within LNs. 295 However, regarding the migration to LNs there are two interesting situations that require additional synergistic and sequential GPCR signals for efficient trafficking to the LN ( Figure 3B ,E). One example are LC that first need to detach 296 from the epidermis and as an initial migratory step, need to cross the basal membrane and migrate to the dermis. This primary migratory event appears to be independent of CCR7 but rather utilizes various context-dependent GPCRs. [297] [298] [299] While LC migrate to the dermis they upregulate CCR7 and enter lymphatic vessel similar to cDC in a secondary migratory step. Consequently, LC require significantly more time to emigrate from the skin than dermal cDC.
Interestingly, it has been recently demonstrated that a subset of dermal DC also shows a two-step migration pattern. 300, 301 In particular, CD301b expressing dermal DC require CCR8 in the context of Th2 priming conditions in order to cross the subcapsular sinus of the LN. In this situation, CCR8 does not promote chemotaxis itself but rather potentiates the effect of CCR7-mediated migration. A similar requirement for CCR8 has been observed for the migration of moDC from the skin to draining LNs. 302 However, why the migration of CD301b DC and moDC, in contrast to other dermal DC subsets, is regulated via this second migration step and why CCR7-mediated signals are sufficient to drive emigration of these DC from the skin, yet insufficient to promote the full immigration to the LN requires further investigations.
While DC migration to the dLN is overall dominated by CCR7, skin DC clustering around macrophages based on CXCL2-mediated recruitment. 307 In order to resolve the exact mode(s) of migration in these scenarios, it will be required to determine whether the chemoattractants at play are soluble or immobilized and how DC interpret combinations of chemokines in these situations.
In contrast to cDC that predominantly express homeostatic GPCRs, pDC are additionally equipped with inflammatory GPCRs like CCR2, CCR5, and CXCR3. This is reminiscent to NK cells, ILC1, Th1 cells, and effector CD8 T cells, cell types that cooperate to eliminate intracellular pathogens. In the steady state pDC that reside in SLO are primarily localized in the paracortex, yet appear to be enriched at the interfollicular area of the LN similar to memory CD8 T cells. 170, 172 Interestingly, when we analyzed the migratory behavior of pDC during viral infections, we found that pDC accumulate at two different anatomical sites of the LN already a few hours after infection. One group of pDC migrates to the subcapsular sinus area where they interact with virally infected sinus-lining macrophages. 172, 308 By contrast, a second group of pDC migrates toward recently activated CD8 T cells that interact with antigen-presenting cDC. Mechanistically, these sites emit different chemokine cues exposing the responding cells to competitive signals ( Figures 3C and 4) . same GPCRs rather show synergistic functions on T cells. 237 On the other hand, it is quite likely that cell type-specific differences exist and that some GPCR's synergize in one cell type, yet may have crossinhibiting functions in others. In fact, even on a single cell level, heterogeneity between cells may contribute to the "decision-making" process in conflicting chemokine fields ( Figure 4C ). The assumption that both GPCRs (CCR5 and CXCR3) are expressed homogenously on pDC is rather unlikely and instead a range of expression patterns across a population may underlie the single cell behavior seen in vivo.
In other words, pDC may not integrate opposing signals while they migrate through tissues but are rather geared to preferentially follow certain cues a priori. This preference may be further hard wired by downstream or inhibitory molecules of the respective GPCR signaling pathway.
While some chemokine gradients may drive DC to opposing sites, others may synergize to optimize the recruitment process ( Figure 3A,B) . However, it is often difficult to discern between redundancy vs synergy of GPCRs as many in vivo studies rely on end-point analyses of gene-deficient animals. However, there are a couple of examples that likely reflect synergistic effects of GPCR signaling in guiding DC migration in vivo. It has been shown that the abundance of cDC1 and expression of CCR7 within tumors is a prognostic marker of clinical outcomes. 309, 310 Recent evidence supports a critical role for intratumoral NK cells in recruiting cDC1 within the tumor which is essential for effective immune responses against cancer. 311 This recruitment appears to be based on synergistic effects of NK cell-derived CCL5 and XCL1. Another example is the role of CCL17 for DC emigration from the skin in the context of Th2 responses. 299 In vitro, DC-derived CCL17 synergizes with CCR7-mediated signals to optimize directionality and speed of DC migration. Mechanistically, this synergistic effect is not based on altered surface expression of CCR7 in the presence or absence or CCL17 but rather on downstream signaling events involving enhanced Ca 2+ flux. In vivo this results in a significant reduction in DC migration to dLN in the absence DC-derived CCL17. Finally, pDC trafficking into the white pulp of the spleen was shown to be based on a cooperative action between CCR7 and CXCR4. 277 Overall cDC migration seems to be dominated by CCR7-mediated navigation reflecting the functional maturation of DC and trafficking from tissues to dLNs. 249 However, at a closer look we find that DC fine-tune their migratory behavior using multiple GPCR in order to populate specific microanatomical niches that are critical to mount adaptive immunity or to orchestrate effector responses in tissues.
172,307,311
| CON CLUS ION
In vivo cellular migration is a highly complex process and we observe different migratory patterns dependent on the chemoattractant, the engaged GPCR, intracellular regulatory proteins, the leukocyte subset, and the nature of the tissue. Some of the observed migratory patterns can be well explained by single GPCRs that may dominate under specific conditions. In reality, however, there are typically several GPCRs engaged simultaneously or sequentially and the responding cells need to integrate these signals. Some of these signals may be synergistic, while others are conflicting. Adding to the intricacy is the fact that some chemokines are agonistic to one receptor, yet maybe antagonistic to another one. 312 Additionally, MMP-mediated degradation of agonistic chemokines can result in products that are antagonistic to the same chemokine receptor. 313 the capability to sharply control chemokine release in situ. 314 With such approaches we will be able to directly control and experimentally influence leukocyte migration in vivo instead of being mere observers. On the other hand, we still lack detailed data on how specific GPCRs modulate the migratory behavior of different cell types in different tissues. In many studies the migratory behavior of leukocytes is not directly visualized. Instead, conclusions were drawn based on "end-point" differences using animals that are deficient for a specific GPCR. Optimally, loss-and gain-of-function conditions should be visualized directly side-by-side in vivo. GPCRs coupled to fluorescent proteins will further allow us to visualize GPCR internalization and desensitization events. With new tools being developed, continuous technical advancements in intravital microscopy and artificial intelligence supporting the analysis and modeling of imaging data we are confident that many obstacles will be overcome. 
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